Predict your next investment

Staten Biotechnology company logo
HEALTHCARE | Biotechnology
statenbiotech.com

See what CB Insights has to offer

Founded Year

2014

Stage

Other Investors | Alive

About Staten Biotechnology

Staten Biotechnology develops technology and strategies for the prevention of cardiovascular events. Staten develops a human monoclonal antibody with an approach towards neutralizing apoC3 - a molecule in dyslipidemia managemen - which reduces triglyceride levels and increases the removal of atherogenic lipoprotein remnant particles.

Staten Biotechnology Headquarter Location

Transistorweg 5J

Nijmegen, 6534,

Netherlands

+31 357606500

Latest Staten Biotechnology News

Novo-partner indleder forsøg i mennesker med middel mod hjerte-kar-sygdom

Jul 23, 2020

Staten Biotechnology, som Novo Nordisk i 2018 indgik partnerskab med, har indledt kliniske studier med et potentielt middel mod hjerte-kar-sygdom. En købsoption giver danskerne mulighed for senere at overtage det hollandske selskab. Novo Nordsik er trådt et skridt nærmere potentielt opkøb af det hollandske biotekselska Staten Biotechnology Foto: Tidsvilde Stine/Ritzau Scanpix

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Staten Biotechnology Patents

Staten Biotechnology has filed 6 patents.

The 3 most popular patent topics include:

  • Biotechnology
  • Molecular biology
  • Virus families
patents chart

Application Date

Grant Date

Title

Related Topics

Status

1/7/2019

8/17/2021

Molecular biology, Virus families, Biotechnology, Lipid disorders, Fatty acids

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

1/7/2019

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

8/17/2021

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Molecular biology, Virus families, Biotechnology, Lipid disorders, Fatty acids

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Staten Biotechnology Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Staten Biotechnology Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.